Indaptus Therapeutics, Inc. - Common Stock (INDP)

Historical Holders from Q3 2021 to Q2 2025

Symbol
INDP on Nasdaq
CUSIP
45339J105
Type / Class
Equity / Common Stock
Shares outstanding
14.1M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-17
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Indaptus Therapeutics, Inc. - Common Stock (INDP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
YA II PN, Ltd. 9.99% $776K 1.41M YA II PN, Ltd. Feb 13, 2025

Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock (INDP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$354K 0
2025 Q1 643K $354K +$16.7K $0.55 17
2024 Q4 638K $540K +$18.7K $0.84 19
2024 Q3 605K $750K +$5.99K $1.24 17
2024 Q2 600K $1.26M +$23.9K $2.12 21
2024 Q1 588K $1.31M -$24.5K $2.24 17
2023 Q4 602K $1.06M +$56.3K $1.76 18
2023 Q3 571K $1.57M -$25.7K $2.76 16
2023 Q2 584K $1.11M +$8.43K $1.91 15
2023 Q1 579K $1.08M -$60.1K $1.85 15
2022 Q4 576K $838K +$5.92K $1.45 15
2022 Q3 566K $1.22M +$147K $2.16 11
2022 Q2 500K $1.31M -$3.19M $2.61 11
2022 Q1 1.69M $6.75M -$661K $4.00 9
2021 Q4 1.84M $10.5M +$6.51M $5.70 11
2021 Q3 541K $4.24M +$4.24M $7.82 9